InvestorsHub Logo

schiltgen

08/13/07 9:44 PM

#541 RE: bookert #540

David Gelbaum buys 3,444,700 shares of OCTL 6.7% of the company.

http://secfilings.nasdaq.com/filingFrame...

http://www.octillioncorp.com/
http://finance.yahoo.com/q?s=octl.pk


Research Breakthrough Spurs Octillion to Accelerate Development of Glass Windows Able to Generate Electricity
Monday July 23, 9:15 am ET
Octillion doubles funding for research and development after researchers successfully create mechanically stable developmental prototype.


VANCOUVER, British Columbia--(BUSINESS WIRE)--Octillion Corp. (Pink Sheets:OCTL - News) today announced that the Company has doubled its research funding in order to accelerate development of the first-of-its-kind transparent glass window capable of generating electricity, following encouraging research outcomes and completion of a developmental prototype window, a major breakthrough milestone.
ADVERTISEMENT


Last month, researchers created an early lab scale model of Octillion's transparent photovoltaic 'NanoPower Window'. Scientists successfully engineered and assembled a mechanically stable, see-through developmental prototype, which achieved optically active down-conversion and displayed good electrical properties with no electrical shorts.

"Recently, we've been fortunate to accomplish significant breakthroughs, and as a result, I'm proud to announce that Octillion has now formally committed to doubling our research funding pursuant to our Sponsored Research Agreement, which allows our collaborating scientists to more aggressively exploit these important findings," explained Octillion President and CEO, Mr. Harmel S. Rayat.

Key to the development of Octillion's transparent NanoPower Windows is a proprietary spray coating of a silicon nanoparticle film, which is fluorescent and able to convert the sun's energy into electricity. The process of producing these silicon nanoparticles is supported by 10 issued US patents, 7 pending US patents, 2 issued foreign counterpart patents and 19 pending foreign counterpart patents.